fluorodeoxyglucose f18 has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (27.03) | 29.6817 |
| 2010's | 18 (48.65) | 24.3611 |
| 2020's | 9 (24.32) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, A; Prakash, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Deroose, CM; Dierickx, D; Janssens, A; Laenen, A; Tousseyn, T; Vergote, VKJ; Verhoef, G; Woei-A-Jin, FJSH | 1 |
| Bailly, C; Bodet-Milin, C; Carlier, T; Frecon, G; Kraeber-Bodere, F; Le Gouill, S; Macintyre, E; Morvant, C; Safar, V; Tournilhac, O | 1 |
| Laffon, E; Marthan, R | 1 |
| Bailly, C; Bodet-Milin, C; Carlier, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
| Cheah, CY; El-Galaly, TC | 1 |
| AbuduRxiti, M; Fu, L; Li, H; Qin, Y; Wang, Q; Wu, J; Yang, S; Zou, X | 1 |
| Braun, T; Playe, M; Siavellis, J; Soussan, M | 1 |
| Chen, W; Desai, A; Gong, T; Nomie, K; Romaguera, J; Wang, ML; Wang, W; Ye, H; Zeng, D | 1 |
| Jensen, A; Kamdar, M; Kwak, J; Morgan, R; Perry, M | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D | 1 |
| Albano, D; Bertagna, F; Bianchetti, N; Bosio, G; Giubbini, R; Pagani, C; Re, A; Tucci, A | 1 |
| Bailly, C; Berriolo-Riedinger, A; Bodet-Milin, C; Burroni, B; Carlier, T; Casasnovas, O; Devillers, A; Djaileb, L; Gressin, R; Gyan, E; Hermine, O; Kraeber-Bodéré, F; Lamy, T; Le Gouill, S; Meignan, M; Moreau, A; Thieblemont, C | 1 |
| Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
| Avigdor, A; Avivi, I; Benyamini, N; Davidson, T; Goshen, E; Kedmi, M; Nagler, A; Ribakovsky, E; Tadmor, T | 1 |
| Irie, T; Izumiyama, K; Miyashita, K; Miyazaki, M; Mori, A; Morioka, M; Saito, M; Tanaka, M; Tanaka, S; Tanino, M; Tsukamoto, E | 1 |
| Banzo, I; Carril, JM; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R | 1 |
| Chen, Q; Chen, W; Dilsizian, V; Kimball, AS; Rezaee, A | 1 |
| Agarwal, KK; Bal, C; Gogia, A; Kumar, R; Mukherjee, A | 1 |
| Karabulut, N; Karaman, E; Ufuk, F | 1 |
| Czuczman, MS; Graf, DA; Lamonica, D; Munteanu, MC | 1 |
| Gill, S; Hicks, RJ; Januszewicz, H; Prince, HM; Ritchie, D; Seymour, JF; Wolf, M | 1 |
| Gill, S; Hicks, RJ; Seymour, JF | 1 |
| Brepoels, L; De Wever, W; De Wolf-Peeters, C; Dierickx, D; Mortelmans, L; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G | 1 |
| Ata, A; Brepoels, LM; Chundru, S; Douglas-Nikitin, V; Feustel, PJ; Irish, K; Karam, M; Mottaghy, FM; Oliver Wong, CY; Stroobants, SG; Verhoef, GE | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Seker, M; Ustaalioglu, BB | 1 |
| Bodet-Milin, C; Gallazini-Crépin, C; Gressin, R; Gries, P; Harousseau, JL; Jardel, H; Kraeber-Bodere, F; Le Gouill, S; Leux, C; Maisonneuve, H; Mohty, M; Moreau, A; Moreau, P; Morineau, N; Sahin, M; Touzeau, C | 1 |
| Ishizawa, K; Ogura, M; Tateishi, U; Tatsumi, M; Terauchi, T; Tobinai, K | 1 |
| Ramsdale, E; Smith, SM; van Besien, K | 1 |
| Alavi, A; Aydin, A; Schuster, S; Shrikanthan, S; Talanow, R | 1 |
| Buck, AK; Dechow, T; Graf, N; Herrmann, K; Keller, U; Peschel, C; Rudelius, M; Scheuerer, C; Schuster, T; Schwaiger, M; Wester, HJ | 1 |
| Beuthien-Baumann, B; Naumann, R | 1 |
| Losik, SB; Margouleff, D; Studentsova, Y | 1 |
| Alavi, A; Bhargava, P; Kumar, R; Schuster, SJ; Yu, JQ; Zhuang, H | 1 |
| Kosaka, S; Okamura, T; Shinohara, M; Yamamoto, T | 1 |
| Banzo, I; Barragán, JE; Carril, JM; Jiménez-Bonilla, JF; López-Cordovilla, JJ; Martínez-Rodríguez, I; Quirce, R; Sainz-Esteban, A | 1 |
| Alavi, A; Farner, MC; Levine, MS; Sam, JW; Schuster, SJ | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography | 2008 |
Personalized treatment of lymphoma: promise and reality.
Topics: Cancer Vaccines; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Precision Medicine | 2011 |
4 trial(s) available for fluorodeoxyglucose f18 and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Positron emission tomography in mantle cell lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2011 |
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.
Topics: Aged; Aged, 80 and over; Biological Transport; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lymphoma, Mantle-Cell; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Time Factors; Treatment Outcome | 2011 |
31 other study(ies) available for fluorodeoxyglucose f18 and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
"Hood Sign" in Nuclear Medicine: An Unusual Presentation of Mantle Cell Lymphoma as Detected on FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
[
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Topics: Adult; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Prognostic value of
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Reply to E. Laffon
Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Prognosis | 2020 |
Mantle cell lymphoma - where precision medicine based on response-adapted treatment strategies could show its full worth.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Precision Medicine; Prognosis | 2020 |
Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma.
Topics: Adult; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
FDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19: Typical Findings.
Topics: Adult; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, Mantle-Cell; Middle Aged; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Spontaneous regression of mantle cell lymphoma: a report of four cases.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Regression, Spontaneous; Positron Emission Tomography Computed Tomography | 2018 |
Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma.
Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2018 |
18F-FDG PET/CT in Intramuscular Mantle Cell Lymphoma With Elongated Lymphomatous Neurovascular Extension.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Muscle, Skeletal; Positron Emission Tomography Computed Tomography | 2019 |
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Treatment Outcome | 2019 |
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2020 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Vincristine | 2014 |
¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
Topics: Adenomatous Polyps; Cell Proliferation; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestinal Polyposis; Ki-67 Antigen; Lymphoma, Mantle-Cell; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnosis of mantle-cell lymphoma relapse by 18F-FDG PET/CT after water gastric distention.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Water | 2014 |
Giant Cell Tumor of the Tendon Sheath With Discordant Metabolism as a False Positive on Staging of Mantle Cell Lymphoma.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Kidney; Lymphoma, Mantle-Cell; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Perirenal Involvement of Mantle Cell Lymphoma: Imaging Features.
Topics: Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma, Mantle-Cell; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2008 |
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
Topics: Belgium; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; United States | 2009 |
F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Polyradiculopathy; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2010 |
Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Sensitivity and Specificity | 2011 |
Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Chemotherapy-induced pericarditis on F-18 FDG positron emission tomography scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Middle Aged; Pericarditis; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Neurological picture. FDG-PET in meningeal lymphomatosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Meningeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
In-111 ibritumomab scintigraphy (planar and SPECT) and FDG PET/CT before Y-90 ibritumomab treatment in a patient with mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lymphoma, Mantle-Cell; Male; Positron-Emission Tomography; Radioimmunotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography.
Topics: Colonoscopy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intestine, Small; Lymphoma, Mantle-Cell; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |